Go­ing glob­al, Take­da opens up 165,000-square-foot R&D fa­cil­i­ty in San Diego

Months af­ter con­sum­mat­ing its hefty $62 bil­lion deal to buy Ire­land’s Shire, Japan­ese drug­mak­er Take­da is strength­en­ing its roots in the Unit­ed States and en­rich­ing its glob­al re­search heft, by un­veil­ing a 165,000-square-foot fa­cil­i­ty in San Diego, Cal­i­for­nia, in ad­di­tion to its ex­ist­ing R&D cen­ter in Cam­bridge, Mass­a­chu­setts and plant in Shonan, Japan.

The new fa­cil­i­ty, an­nounced on Tues­day, will ex­tend Take­da’s $TAK 14-year pres­ence in San Diego, and is home to more than 250 em­ploy­ees fo­cused on R&D re­lat­ed to gas­troen­terol­o­gy and neu­ro­science.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER